Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
Company Growth (employees)
Type
Public
HQ
Emeryville, US
Founded
2006
Size (employees)
67 (est)
Zogenix was founded in 2006 and is headquartered in Emeryville, US

Zogenix Office Locations

Zogenix has offices in Emeryville, San Diego and Maidenhead
Emeryville, US (HQ)
455 5858 Horton St
Maidenhead, GB
Broadway
San Diego, US
650 12400 High Bluff Dr

Zogenix Financials and Metrics

Zogenix Financials

Zogenix's revenue was reported to be $28.9 m in FY, 2016
USD

Revenue (Q2, 2017)

7.1 m

Net income (Q2, 2017)

(23 m)

EBIT (Q2, 2017)

(22.1 m)

Market capitalization (13-Nov-2017)

966.4 m

Cash (30-Jun-2017)

65.8 m

EV

904 m
Zogenix's current market capitalization is $966.4 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

33 m40.5 m27.2 m28.9 m

Revenue growth, %

23%(33%)6%

Cost of goods sold

21.2 m15.8 m

Gross profit

11.8 m24.7 m27.2 m28.9 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

7.2 m7.7 m9.2 m8.8 m4.6 m7.4 m9.1 m9.2 m2.1 m6.6 m7.1 m

Cost of goods sold

5.4 m3.4 m2.4 m706 k

Gross profit

1.8 m4.3 m6.8 m8.1 m

Gross profit Margin, %

25%56%74%92%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

72 m42.2 m155.3 m91.6 m

Accounts Receivable

1.4 m1.4 m

Inventories

4.3 m13.4 m12 m12 m

Current Assets

92.9 m78 m184.6 m119.9 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

17.4 m50.7 m81.2 m50.5 m21.3 m77.4 m162.7 m132.2 m127.8 m109.9 m80.1 m65.8 m

Accounts Receivable

6.2 m11.7 m5.9 m5.9 m1.6 m6 m3.9 m4.9 m2.1 m6.5 m

Inventories

12.1 m14.9 m15.7 m19.3 m13.1 m12.6 m10.3 m9.5 m11.9 m9.4 m9.1 m2.2 m

Current Assets

37.4 m81 m116.5 m90.6 m55.2 m125.3 m200.6 m163.1 m149.5 m135.3 m98.8 m78.8 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(80.9 m)8.6 m26.1 m(69.7 m)

Depreciation and Amortization

1.8 m1.6 m1.6 m1.4 m

Accounts Receivable

(1 m)(2.2 m)7.5 m7.5 m

Inventories

(2 m)(9.2 m)(743 k)(743 k)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(45.2 m)49.6 m35 m(10.4 m)(29.2 m)(46.2 m)

Depreciation and Amortization

1.4 m406 k820 k1.2 m393 k814 k1.2 m378 k694 k966 k

Accounts Receivable

(518 k)(5 m)745 k779 k4.2 m2.6 m4.9 m(3.5 m)(712 k)(5.1 m)

Inventories

542 k3 m2.6 m186 k2.6 m
Y, 2017

EV/EBIT

-40.9 x

Financial Leverage

2.4 x
Show all financial metrics

Zogenix Market Value History

Zogenix's Web-traffic and Trends

Zogenix Online and Social Media Presence

Zogenix Company Life and Culture

You may also be interested in